[1] Capon F, Dallapiccola B, Novelli G.. Advances in the search for psoriasis susceptibility genes. Mol Genet Metab, 2000, 71(1-2): 250-255. [2] Duffy DL, Spelman LS, Martin NG.. Psoriasis in Australian twins. J Am Acad Dermatol,1993, 29(3):428-434. [3] Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet, 2007, 80(2):273-290. [4] Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21.Nat Genet , 2009,41(2):205-210. [5] Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet,2009, 41(2):199-204. [6] 张学军.皮肤性病学[M].7版.北京:人民卫生出版社,2008 ,141-144. [7] Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res, 2005,15(2):97-98. [8] Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol, 1996,135(4):533-537,. [9] Simons RD. Additional studies on psoriasis in the tropics and in starvation camps. J Invest Dermatol, 1949,12(5):285-294. [10] Yip SY.The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol,1984, 10(6):965-968. [11] Kader H A,Tchernev V T,Satyaraj E,et a1.Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated sernm PLGF, IL-7, TGF-betal,and IL-12p40 levels in Crohn s disease and ulcerative colitis patients in remission versus active disease.Am J Gastroenterol,2005,100(2):414-423. [12] Yen D,Cheung J,Scheerens H,et a1.IL-23 is essential for T cel1.mediated colitis and promotes inflanimation via IL-17 and IL-6.J Clin Invest,2006,116(5):1310-1316. [13] Nickolof B J.Cracking the cytokine code in psoriasis.Nat Med,2007,13(3):242-244. [14] Bettelli E,Kuchroo V K.IL-12 and IL-23-induced T helper cell subsets:birds of the same feather flock together.J Exp Med,2005,201(2):169-171. [15] Afican O,Aral M,Sasmaz S,et a1.Serum levels of TNF-alpha,IFN-gamma,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity.Mediators Inflamm,2005,2005(5):273-279. [16] Cheng J,Tu Y,Li J,et a1.A study on the expression of interleukin(IL)-10 and IL-12 P35,P40 mRNA in the psoriatic lesions.J Tongji Med Univ,2001,21(1):86-88. [17] Lew W ,E Lee,Krueger J G.Psoriasis genomics:analysis of proinflammatory( type 1)gene expression in large plaque(Western) and small plaque(Asian)psoriasis vulgaris.Br J Dermatol,2004,150(4):668-676. [18] Lee E,Trepicchio W L,Oestreicher J L,et a1.Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.J Exp Med,2004,199(1):125-130. [19] Chan J R,Blumenschein W,Murphy E,et a1.IL-23 stimulates epidermal hypcrplasia via TNF and IL-20R2--dependent mechanisms with implications for psoriasis pathogenesis.J Exp Med,2006,203(12):2577-2587. [20] Nair RP, Ruether A, Stuart PE, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol,2008, 128(7):1653,-1661. [21] Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet ,2008,4(3):e1000041. [22] Smith RL, Warren RB, Eyre S, et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. J Invest Dermatol,2008, 128(5):1325-1327. [23] Einarsdottir E, Koskinen LL, Dukes E, et al. IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet,2009,10:8. [24] Huffmeier U, Lascorz J, Bohm B, et al. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol,2009, 129(2):355-358. [25] Li Y, Chang M, Schrodi SJ, et al. The 5q31 variants associated with psoriasis and Crohn's disease are distinct. Hum Mol Genet,2008, 17(19):2978-2985. [26] Capon F, Di Meglio P, Szaub J, et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet,2007, 122(2):201-206. [27] Garcia VE, Chang M, Brandon R,et al.Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes Immun,2008, 9(6):546-555. [28] Kai Wang HZ, Subra Kugathasan, Vito Annese, et al. Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease. Am J Hum Genet,2009, 84(3):399-405. [29] Filer C, Ho P, Smith RL, et al. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum,2008, 58(12):3705-3709. [30] Marquez A, Mendoza JL, Taxonera C, et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis,2008, 14(9):1192-1196. [31] Sanchez E, Rueda B, Callejas JL, et al. Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens,2007, 70(3):233-237. [32] Mangino M, Braund P, Singh R, et al. Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction. J Mol Med,2008, 86(1):99-103. [33] Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol,2007,25:221-242. |